National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 9 of 1992)

Administered by Department of Health, Disability and Ageing

Legislation au F2007B01082 Not in force Legislative Instrument

Legislation content

 

 

 

 

 

 

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85 (2AA)

 

No. PB 9 of 1992

 

I, DENISE MARY SWIFT, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health, Housing and Community Services and Delegate of the Minister of State for Health, Housing and Community Services, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:

 

1. This Declaration shall come into operation on 1 August 1992.

 

2. The drug calcium glubionate shall cease to be a drug to which Part VII of the National Health Act 1953 applies.

 

 

Dated this fourteenth day of July 1992.

 

 

 

DENISE SWIFT 

Acting Assistant Secretary

Pharmaceutical Benefits Branch

Department of Health, Housing and Community Services

Delegate of the Minister of State for Health, Housing and Community Services

 

 

 

 

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.